{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:16Z","timestamp":1776329836354,"version":"3.50.1"},"reference-count":40,"publisher":"Baskent University","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.6002\/ect.2020.0130","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T03:30:01Z","timestamp":1607398201000},"page":"370-379","source":"Crossref","is-referenced-by-count":0,"title":["Factors Affecting Bone Health in Kidney Transplant Recipients: Klotho Gene Single-Nucleotide Polymorphisms and Other Clinical Features"],"prefix":"10.6002","volume":"20","author":[{"given":"Hasan H.","family":"Yeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozant","family":"Helvaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berfu","family":"Korucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevim","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galip","family":"Guz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulver","family":"Derici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Kulak CA, Borba VZ, Kulak Junior J, Custodio MR. Bone disease after transplantation: osteoporosis and fractures risk. Arq Bras Endocrinol Metabol. 2014;58(5):484-492. doi:10.1590\/0004-2730000003343","DOI":"10.1590\/0004-2730000003343"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Vangala C, Pan J, Cotton RT, Ramanathan V. Mineral and bone disorders after kidney transplantation. Front Med (Lausanne). 2018;5:211. doi:10.3389\/fmed.2018.00211","DOI":"10.3389\/fmed.2018.00211"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Damasiewicz MJ, Ebeling PR. Management of mineral and bone disorders in renal transplant recipients. Nephrology (Carlton). 2017;22 Suppl 2:65-69. doi:10.1111\/nep.13028","DOI":"10.1111\/nep.13028"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Pihlstrom H, Dahle DO, Mjoen G, et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation. 2015;99(2):351-359. doi:10.1097\/TP.0000000000000583","DOI":"10.1097\/TP.0000000000000583"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Marchelek-Mysliwiec M, Rozanski J, Ogrodowczyk A, et al. The association of the Klotho polymorphism rs9536314 with parameters of calcium-phosphate metabolism in patients on long-term hemodialysis. Ren Fail. 2016;38(5):776-780. doi:10.3109\/0886022X.2016.1162062","DOI":"10.3109\/0886022X.2016.1162062"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Deng G, Liu D. Klotho: a promising biomarker closely related to kidney transplant. Exp Clin Transplant. 2018;16(3):253-258. doi:10.6002\/ect.2017.0329","DOI":"10.6002\/ect.2017.0329"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444(7120):770-774. doi:10.1038\/nature05315","DOI":"10.1038\/nature05315"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Hardcastle MR, Dittmer KE. Fibroblast growth factor 23: a new dimension to diseases of calcium-phosphorus metabolism. Vet Pathol. 2015;52(5):770-784. doi:10.1177\/0300985815586222","DOI":"10.1177\/0300985815586222"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Canalejo R, Canalejo A, Martinez-Moreno JM, et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol. 2010;21(7):1125-1135. doi:10.1681\/ASN.2009040427","DOI":"10.1681\/ASN.2009040427"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Ozdem S, Yilmaz VT, Ozdem SS, et al. Is Klotho F352V polymorphism the missing piece of the bone loss puzzle in renal transplant recipients? Pharmacology. 2015;95(5-6):271-278. doi:10.1159\/000398812","DOI":"10.1159\/000398812"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Baldwin C, Nolan VG, Wyszynski DF, et al. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood. 2005;106(1):372-375. doi:10.1182\/blood-2005-02-0548","DOI":"10.1182\/blood-2005-02-0548"},{"key":"ref11","unstructured":"12. Nazarian A, Hasankhani M, Aghajany-Nasab M, Monfared A. Association between klotho gene polymorphism and markers of bone metabolism in patients receiving maintenance hemodialysis in Iran. Iran J Kidney Dis. 2017;11(6):456-460."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Ogata N, Matsumura Y, Shiraki M, et al. Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone. 2002;31(1):37-42. doi:10.1016\/s8756-3282(02)00786-x","DOI":"10.1016\/S8756-3282(02)00786-X"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Andrassy KM. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. Kidney Int. 2013;84(3):622-623. doi:10.1038\/ki.2013.243","DOI":"10.1038\/ki.2013.243"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9 Suppl 3:S1-155. doi:10.1111\/j.1600-6143.2009.02834.x","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Taweesedt PT, Disthabanchong S. Mineral and bone disorder after kidney transplantation. World J Transplant. 2015;5(4):231-242. doi:10.5500\/wjt.v5.i4.231","DOI":"10.5500\/wjt.v5.i4.231"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Sirilak S, Chatsrisak K, Ingsathit A, et al. Renal phosphate loss in long-term kidney transplantation. Clin J Am Soc Nephrol. 2012;7(2):323-331. doi:10.2215\/CJN.06380611","DOI":"10.2215\/CJN.06380611"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev. 1991;71(2):371-411. doi:10.1152\/physrev.1991.71.2.371","DOI":"10.1152\/physrev.1991.71.2.371"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Van de Cauter J, Sennesael J, Haentjens P. Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study. Transplant Proc. 2011;43(9):3470-3475. doi:10.1016\/j.transproceed.2011.09.030","DOI":"10.1016\/j.transproceed.2011.09.030"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Cho MS, Lee KS, Lee YK, et al. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med. 2002;17(2):114-121. doi:10.3904\/kjim.2002.17.2.114","DOI":"10.3904\/kjim.2002.17.2.114"},{"issue":"3","key":"ref20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/089686080602600315","article-title":"Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review","volume":"26","author":"Wei","year":"2006","unstructured":"21. Wei M, Esbaei K, Bargman J, Oreopoulos DG. Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int. 2006;26(3):366-373.","journal-title":"Perit Dial Int"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Neyra JA, Hu MC. \u03b1Klotho and chronic kidney disease. Vitam Horm. 2016;101:257-310. doi:10.1016\/bs.vh.2016.02.007","DOI":"10.1016\/bs.vh.2016.02.007"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Komaba H, Lanske B. Role of Klotho in bone and implication for CKD. Curr Opin Nephrol Hypertens. 2018;27(4):298-304. doi:10.1097\/MNH.0000000000000423","DOI":"10.1097\/MNH.0000000000000423"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Zheng S, Chen Y, Zheng Y, Zhou Z, Li Z. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients. Eur J Med Res. 2018;23(1):18. doi:10.1186\/s40001-018-0315-z","DOI":"10.1186\/s40001-018-0315-z"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Komaba H, Goto S, Fujii H, et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int. 2010;77(3):232-238. doi:10.1038\/ki.2009.414","DOI":"10.1038\/ki.2009.414"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Ball AM, Gillen DL, Sherrard D, et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA. 2002;288(23):3014-3018. doi:10.1001\/jama.288.23.3014","DOI":"10.1001\/jama.288.23.3014"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med. 1991;325(8):544-550. doi:10.1056\/NEJM199108223250804","DOI":"10.1056\/NEJM199108223250804"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Kulak CA, Borba VZ, Kulak J Jr, Custodio MR. Osteoporosis after transplantation. Curr Osteoporos Rep. 2012;10(1):48-55. doi:10.1007\/s11914-011-0083-y","DOI":"10.1007\/s11914-011-0083-y"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Woodle ES, First MR, Pirsch J, et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg. 2008;248(4):564-577. doi:10.1097\/SLA.0b013e318187d1da","DOI":"10.1097\/SLA.0b013e318187d1da"},{"issue":"10","key":"ref29","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1681\/ASN.V11101910","article-title":"A meta-analysis of immunosuppression withdrawal trials in renal transplantation","volume":"11","author":"Kasiske","year":"2000","unstructured":"30. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol. 2000;11(10):1910-1917.","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Arking DE, Krebsova A, Macek M, Sr., et al. Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A. 2002;99(2):856-861. doi:10.1073\/pnas.022484299","DOI":"10.1073\/pnas.022484299"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Riancho JA, Valero C, Hernandez JL, et al. Association of the F352V variant of the Klotho gene with bone mineral density. Biogerontology. 2007;8(2):121-127. doi:10.1007\/s10522-006-9039-5","DOI":"10.1007\/s10522-006-9039-5"},{"issue":"2","key":"ref32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/gei.s2626","article-title":"Sickle cell disease in the post genomic era: a monogenic disease with a polygenic phenotype","volume":"2009","author":"Driss","year":"2009","unstructured":"33. Driss A, Asare KO, Hibbert JM, Gee BE, Adamkiewicz TV, Stiles JK. Sickle cell disease in the post genomic era: a monogenic disease with a polygenic phenotype. Genomics Insights. 2009;2009(2):23-48.","journal-title":"Genomics Insights"},{"issue":"2","key":"ref33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Assouline-Dayan","year":"2002","unstructured":"34. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94-124.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/archinte.1978.03630290052018","article-title":"Relationship to corticosteroid therapy","volume":"138","author":"Abeles","year":"1978","unstructured":"35. Abeles M, Urman JD, Rothfield NF. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med. 1978;138(5):750-754.","journal-title":"Arch Intern Med"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985;79(5):596-604. doi:10.1016\/0002-9343(85)90057-9","DOI":"10.1016\/0002-9343(85)90057-9"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Kerachian MA, Seguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009;114(3-5):121-128. doi:10.1016\/j.jsbmb.2009.02.007","DOI":"10.1016\/j.jsbmb.2009.02.007"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine. 2006;73(5):500-507. doi:10.1016\/j.jbspin.2006.01.025","DOI":"10.1016\/j.jbspin.2006.01.025"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Felten R, Perrin P, Caillard S, Moulin B, Javier RM. Avascular osteonecrosis in kidney transplant recipients: risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism. PLoS One. 2019;14(2):e0212931. doi:10.1371\/journal.pone.0212931","DOI":"10.1371\/journal.pone.0212931"},{"key":"ref39","unstructured":"40. Nehme D, Rondeau E, Paillard F, et al. Aseptic necrosis of bone following renal transplantation: relation with hyperparathyroidism. Nephrol Dial Transplant. 1989;4(2):123-128."}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T03:27:37Z","timestamp":1651116457000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/current\/2022\/20\/4\/0\/370\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2020.0130","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}